CXCL1 rapidly increased 45-fold 3 h post-infection and then decreased throughout the remainder of the time course, which was in accordance with the development of pleuropneumonia; therefore, CXCL1 might be used as a novel biomarker to test the course of the disease in mice(Fig. 7D). The gene discussed is CXCL1; the disease is infection.